Browse Category

Stocks News 17 October 2025 - 20 October 2025

PetroChina Stock Jumps on Oil Boom, Dividend Windfall & Stablecoin Ambitions

Stock Price on the Rise PetroChina’s Hong Kong-listed H-shares have been on a notable upswing in recent months. On October 20, the stock jumped to HK$7.65, gaining +4.5% in a single session reuters.com reuters.com. Investors bid up the price amid

20 October 2025

Coinbase (COIN) Stock Crashes in Crypto Sell-Off – Can It Bounce Back?

Coinbase Stock’s Wild Surge on Crypto Boom – Will COIN Hit $500 Next? 🚀

Coinbase Stock Rides Crypto’s “Uptober” Wave – Then Whipsaws Coinbase shareholders have been on a wild ride this month. The stock surged from around $313 at late September to $380.02 by October 3 – a ~21% jump in one week

20 October 2025

Coinbase · Cryptocurrency · Market Analysis · NASDAQ:COIN · Stocks · Trading

Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon Stock Braces for Breakout? Inside AMZN’s Wild 2025 Ride and What Comes Next

Stock Performance & Recent Moves Amazon’s headquarters in Seattle. The company’s stock has traded range-bound in 2025 as investors weigh its growth prospects against market headwinds. Amazon’s share price has been range-bound in recent months, entering this week in the

20 October 2025

Amazon · Financial Forecasts · Investing · Market Analysis · NASDAQ:AMZN · Stocks

Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Stock Price & Recent Performance Before the late-September rally, Pfizer’s stock had been trading lethargically. As one analysis notes, PFE closed around $23.60 on Sept. 26, roughly flat for the year and down ~9% since January ts2.tech. Over the prior

19 October 2025

Business News · Investment · Market Analysis · NASDAQ:MTSR · NYSE:PFE · Pharmaceuticals · Stocks

White House’s Shocking 10% Intel Stake Plan Shakes the Tech World

Intel Stock Soars to Multi-Year High on AI Buzz and Big Backers – Will the Rally Last?

Intel Stock Price & Recent Performance Intel’s share price has been on a roller coaster in recent days, reflecting excitement about its prospects tempered by bouts of profit-taking. As of the Oct. 17 market close, INTC traded in the high-$36

18 October 2025

Artificial Intelligence · Investing · Market Analysis · Semiconductors · Stocks

Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple’s stock is trading near record levels as of mid-October 2025. Last week (Oct. 13–17), AAPL shares oscillated in the $247–$252 range, closing at $252.29 on Oct. 17 historicalstockprice.com. That is only a few dollars below the all-time intraday high (~$260) set

18 October 2025

Apple · Artificial Intelligence · Investing · Stocks · Technology

GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

Surging Stock Performance GE Aerospace (NYSE: GE) shares have been on a tear in 2025, roughly doubling from lows. As of Oct 17, 2025, the stock closed around $300 reuters.com. That’s up about 78% this year intelligentinvestor.com.au – one of

18 October 2025

Aerospace · Earnings Reports · Investment News · Market Analysis · NYSE:GE · Stocks

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

Stock Soars on Catalyst News MindMed’s stock has skyrocketed in recent weeks. After languishing in the single digits, MNMD climbed above $12 in late September and spiked to $13.09 on Oct. 14, its highest level in over a year ts2.tech

18 October 2025

Biotech · Investing · Market News · Mental Health · NASDAQ:MNMD · Stocks

BlackRock’s Big Bet Sends SELLAS Life Sciences (SLS) Stock Soaring – What’s Next for This Biotech?

Key Facts – October 18, 2025 Stock Performance: SLS on a Tear in 2025 SELLAS Life Sciences’ stock has been on a remarkable run this year. Shares have effectively doubled in 2025, and the momentum accelerated in mid-October. On Friday

18 October 2025

Biotech · Financial Analysis · Investing · Market News · NASDAQ:SLS · Stocks

Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

In summary, Gilead’s share price has rallied on a wave of HIV-related breakthroughs, pipeline achievements, and upbeat guidance. With third-quarter results due Oct. 30, investors will be watching for sustained growth. For now, analysts remain generally optimistic: the consensus rating

18 October 2025

HIV Treatment · Investment Strategies · Patent News · Pharmaceutical Industry · Stocks

Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Bumpy Ride for CRM Stock in 2025 Salesforce’s stock (NYSE: CRM) has been on a rollercoaster in recent weeks. After a steep September sell-off – when cautious guidance sent shares to multi-month lows around $235 ts2.tech – the stock found

17 October 2025

Artificial Intelligence · Cloud Computing · Market Analysis · NYSE:CRM · Stocks · Technology News

Praxis (PRAX) Stock Skyrockets 180% on Game-Changing Tremor Drug Trial; Analysts See ‘Blockbuster’ Upside

PRAX Stock Soars on Historic Trial Win Praxis Precision Medicines stock has seen a record-breaking spike in recent days after announcing landmark clinical trial results. On October 16, PRAX shares closed at $162.71, up about 183% in a single session

17 October 2025

Biotechnology · Clinical Trials · Investment · NASDAQ:PRAX · Pharmaceuticals · Stocks

Previous 1 … 32 33 34 35 36 … 43 Next

Go toTop